{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-282994","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2026-06-25T21:01:07+00:00","discovered_at":"2026-06-25T21:02:00.245775+00:00","generated_at":"2026-06-25T21:02:13.656832+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ARS Pharma stockholders elect Class III directors, ratify EY, approve say-on-pay","bullets":["Saqib Islam, Phillip Schneider, Laura Shawver elected as Class III directors; Schneider received 38.5M for vs 27.5M withheld.","Ernst & Young ratified as auditor for FY2026 with 79.5M for, 102k against.","Advisory vote on NEO compensation approved with 57.3M for, 8.1M against, 622k abstain.","Advisory vote selects 1-year frequency for future say-on-pay votes (52.1M votes) until 2032 meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-282994","json":"https://secwatch.observer/filing/0001193125-26-282994.json","markdown":"https://secwatch.observer/filing/0001193125-26-282994.md","text":"https://secwatch.observer/filing/0001193125-26-282994.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/0001193125-26-282994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/d26870d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:02:13.656832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}